{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:06:13Z","timestamp":1724112373236},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurgie"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00104-024-02117-7","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T14:14:08Z","timestamp":1719497648000},"page":"773-782","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gastroenteropankreatische neuroendokrine Neoplasien \u2013 Chirurgie im multimodalen Konzept","Gastroenteropancreatic neuroendocrine neoplasms\u2014Surgery in a\u00a0multimodal concept"],"prefix":"10.1007","volume":"95","author":[{"given":"K.","family":"Holzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. K.","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"2117_CR1","first-page":"425","volume":"1","author":"S Oberndorfer","year":"1907","unstructured":"Oberndorfer\u00a0S (1907) Karzinoide Tumoren des D\u00fcnndarmes. Frankf Z Pathol 1:425\u2013432","journal-title":"Frankf Z Pathol"},{"key":"2117_CR2","first-page":"429","volume-title":"Medizin","author":"M Anlauf","year":"2023","unstructured":"Anlauf\u00a0M (2023) Endokrine Chirurgie. In: Bartsch\u00a0DK, Holzer\u00a0K (Hrsg) Medizin. Springer, Berlin, S\u00a0429\u2013438"},{"key":"2117_CR3","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1007\/s002680010232","volume":"24","author":"U Ohrvall","year":"2000","unstructured":"Ohrvall\u00a0U, Eriksson\u00a0B, Juhlin\u00a0C et\u00a0al (2000) Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg 24:1402\u20131408","journal-title":"World J Surg"},{"issue":"3","key":"2117_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000464292","volume":"105","author":"S Partelli","year":"2017","unstructured":"Partelli\u00a0S, Bartsch\u00a0DK, Capdevila\u00a0J (2017) ENETS consensus guidelines for standard of care in neuroendocrine tumours: Surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology 105(3):255\u2013265","journal-title":"Neuroendocrinology"},{"key":"2117_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/jamasurg.2018.3865","volume":"154","author":"MY Zaidi","year":"2019","unstructured":"Zaidi\u00a0MY, Lopez-Agular\u00a0AG, Dillhoff\u00a0M et\u00a0al (2019) Prognostic role of lymph node positivity and number of lymph nodes needed for accurately staging small-bowel neuroendocrine tumors. JAMA Surg 154:134\u2013140","journal-title":"JAMA Surg"},{"key":"2117_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11605-017-3524-9","volume":"22","author":"BM Motz","year":"2018","unstructured":"Motz\u00a0BM, Lorimer\u00a0PD, Boselli\u00a0D et\u00a0al (2018) Optimal lymphadenectomy in small bowel neuroendocrine tumors: Analysis of the NCDB. J\u00a0Gastrointest Surg 22:117\u2013123","journal-title":"J Gastrointest Surg"},{"key":"2117_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00268-020-05884-6","volume":"45","author":"M Evers","year":"2021","unstructured":"Evers\u00a0M, Rinke\u00a0A, R\u00fctz\u00a0J et\u00a0al (2021) Prognostic factors in curative resected locoregional small intestine neuroendocrine neoplasms. World J Surg 45:1109\u20131117","journal-title":"World J Surg"},{"key":"2117_CR8","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.3390\/cancers14153610","volume":"14","author":"DK Bartsch","year":"2022","unstructured":"Bartsch\u00a0DK, Windel\u00a0S, Kanngie\u00dfer\u00a0V et\u00a0al (2022) Vessel-sparing lymphadenectomy should be performed in small intestine neuroendocrine neoplasms. Cancers 14:3610","journal-title":"Cancers"},{"issue":"2","key":"2117_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/bjs.6468","volume":"96","author":"A Frilling","year":"2009","unstructured":"Frilling\u00a0A, Li\u00a0J, Malamutmann\u00a0E et\u00a0al (2009) Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg 96(2):175\u2013184","journal-title":"Br J Surg"},{"key":"2117_CR10","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/bjs.8842","volume":"99","author":"G Capurso","year":"2012","unstructured":"Capurso\u00a0G, Rinzivillo\u00a0M, Bettini\u00a0R et\u00a0al (2012) Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. Br J Surg 99:1480\u20131487","journal-title":"Br J Surg"},{"key":"2117_CR11","doi-asserted-by":"crossref","unstructured":"Daskalakis K, Karakatsanis A, Hessmann O et\u00a0al (2018) Association of a\u00a0prophylactic surgical approach to stage\u00a0IV small intestinal neuroendocrine tumors with survival. JAMA Oncol4(2):183\u2013189","DOI":"10.1001\/jamaoncol.2017.3326"},{"key":"2117_CR12","series-title":"Surg","first-page":"e450","volume-title":"Upfront small bowel resection for small bowel neuroendocrine tumors with synchronous metastases A Propensity-score matched comparative population-based analysis. Ann","author":"S Bennett","year":"2022","unstructured":"Bennett\u00a0S, Coburn\u00a0N, Law\u00a0C et\u00a0al (2022) Upfront small bowel resection for small bowel neuroendocrine tumors with synchronous metastases A Propensity-score matched comparative population-based analysis. Ann. Surg, Bd. 276, S e450\u2013e458"},{"key":"2117_CR13","doi-asserted-by":"crossref","unstructured":"Maurer E, Heinzel-Gutenbrunner M (2022) Relevant prognostic factors in patients with stage\u00a0IV small intestine neuroendocrine neoplasms J Neuroendocrinology34:e13076.","DOI":"10.1111\/jne.13076"},{"issue":"19","key":"2117_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.hpb.2016.12.010","volume":"2017","author":"V Sallinen","year":"2017","unstructured":"Sallinen\u00a0V, Le Large\u00a0TYS, Galeev\u00a0S et\u00a0al (2017) Surveillance strategy for small asymptomatic non-functional pancreatic neuroendocrine tumors\u2014a\u00a0systematic review and meta-analysis. HPB 2017(19):310\u2013320","journal-title":"HPB"},{"key":"2117_CR15","doi-asserted-by":"crossref","unstructured":"Sallinen VJ, Le Large TYS Tieftrunk E et\u00a0al (2018) Prognosis of sporadic resected small (\u3008\u202f2\u202fcm) nonfunctional pancreatic neuroendocrine tumors\u2014a\u00a0multi-institutional study HPB 20: 251\u2013259.","DOI":"10.1016\/j.hpb.2017.08.034"},{"key":"2117_CR16","doi-asserted-by":"publisher","unstructured":"Partelli S, Ramage JK, Massironi S et\u00a0al (2020) Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) \u2264\u202f2\u202fcm: Study Protocol for a\u00a0Prospective Observational Study. Front Med (Lausanne). Dec 23;7:598438. https:\/\/doi.org\/10.3389\/fmed.2020.598438. eCollection 2020. PMID: 33425946","DOI":"10.3389\/fmed.2020.598438"},{"key":"2117_CR17","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/bjs\/znac267","volume":"109","author":"S Partelli","year":"2022","unstructured":"Partelli\u00a0S, Massironi\u00a0S, Zerbi\u00a0A et\u00a0al (2022) Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2\u202fcm: interim analysis of prospective ASPEN trial. Br J Surg 109:1186\u20131190","journal-title":"Br J Surg"},{"key":"2117_CR18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/bjs\/znab088","volume":"108","author":"CM Heidsma","year":"2021","unstructured":"Heidsma\u00a0CM, Engelsman\u00a0AF, van Dieren\u00a0S et\u00a0al (2021) Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA). Br J Surg 108:888\u2013891","journal-title":"Br J Surg"},{"issue":"12","key":"2117_CR19","doi-asserted-by":"publisher","first-page":"e13343","DOI":"10.1111\/jne.13343","volume":"35","author":"B Kos-Kud\u0142a","year":"2023","unstructured":"Kos-Kud\u0142a\u00a0B, Casta\u00f1o\u00a0JP, Denecke\u00a0T et\u00a0al (2023) European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J\u00a0Neuroendocrinol 35(12):e13343. https:\/\/doi.org\/10.1111\/jne.13343","journal-title":"J Neuroendocrinol"},{"key":"2117_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/bjs\/znaa141","volume":"108","author":"C Ricci","year":"2021","unstructured":"Ricci\u00a0C, Partelli\u00a0S, Landoni\u00a0L et\u00a0al (2021) Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis. Br J Surg 108:811\u2013816","journal-title":"Br J Surg"},{"issue":"4","key":"2117_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.surg.2017.11.007","volume":"163","author":"S Partelli","year":"2018","unstructured":"Partelli\u00a0S, Bertani\u00a0E, Bartolomei\u00a0M et\u00a0al (2018) Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms. Surgery 163(4):761\u2013767","journal-title":"Surgery"},{"key":"2117_CR22","doi-asserted-by":"crossref","unstructured":"Bertani E, Fazio N Botteri E et\u00a0al (2014) Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a\u00a0multimodal approach. Surgery 155: 607\u2013614","DOI":"10.1016\/j.surg.2013.12.024"},{"key":"2117_CR23","doi-asserted-by":"publisher","unstructured":"Kjaer J, Clancy TE Thornell A et\u00a0al (2022) Benefit of Primary Tumor Resection in Stage\u00a0IV Grade\u00a01 and\u00a02, Pancreatic Neuroendocrine Tumors A Propensity-Score Matched Cohort Study. Ann Surgery Open Mar 14;3(1):e151 https:\/\/doi.org\/10.1097\/AS9.0000000000000151.","DOI":"10.1097\/AS9.0000000000000151"},{"key":"2117_CR24","doi-asserted-by":"crossref","unstructured":"Pawa N, Clift AK Osmani H et\u00a0al (2018) Surgical Management of Patients with Neuroendocrine Neoplasms of the Appendix: Appendectomy or More. Neuroendocrinology 106(3):242\u2013251","DOI":"10.1159\/000478742"},{"issue":"35","key":"2117_CR25","doi-asserted-by":"publisher","first-page":"e13332","DOI":"10.1111\/jne.13332","volume":"2023","author":"G Kaltsas","year":"2023","unstructured":"Kaltsas\u00a0G, Walter\u00a0T, Knigge\u00a0E et\u00a0al (2023) European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET). J\u00a0Neuroendocrinol 2023(35):e13332","journal-title":"J Neuroendocrinol"},{"key":"2117_CR26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s11864-023-01093-0","volume":"24","author":"E Andrini","year":"2023","unstructured":"Andrini\u00a0E, Lamberti\u00a0G, Alberici\u00a0L et\u00a0al (2023) An update on appendiceal neuroendocrine tumors. Curr Treat Options in Oncol 24:742\u2013756","journal-title":"Curr Treat Options in Oncol"},{"key":"2117_CR27","series-title":"Neuroendocrinoloy","first-page":"144","volume-title":"ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)","author":"UF Pape","year":"2016","unstructured":"Pape\u00a0UF, Niederle\u00a0B, Costa\u00a0F et\u00a0al (2016) ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas). Neuroendocrinoloy, Bd. 103, S\u00a0144\u2013152"},{"key":"2117_CR28","doi-asserted-by":"crossref","unstructured":"Rinke A, Wiedenmann B Auernhammer C et\u00a0al (2018) S2k-Leitlinie Neuroendokrine Tumore. AWMF-Reg. 021-27 Z Gastroenterol 56: 583\u2013681","DOI":"10.1055\/a-0604-2924"},{"key":"2117_CR29","unstructured":"Nesti C Br\u00e4utigam K Benavent M et\u00a0al (2023) Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1\u20132\u202fcm in size: a\u00a0retrospective, Europe-wide, pooled cohort study. Lancet Oncol 24(2):187\u2013194"},{"issue":"13","key":"2117_CR30","doi-asserted-by":"publisher","first-page":"8528","DOI":"10.1245\/s10434-023-14276-8","volume":"30","author":"M Kalifi","year":"2023","unstructured":"Kalifi\u00a0M, Deguelte\u00a0S, Faron\u00a0M (2023) The need for centralization for small intestinal neuroendocrine tumor surgery: A\u00a0cohort study from the GTE-Endocan-RENATEN network, the centralchirSINET study. Ann Surg Oncol 30(13):8528\u20138541","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2117_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel\u00a0M, O\u2019Toole\u00a0D, Costa\u00a0F et\u00a0al (2016) ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. Neuroendocrinology 103(2):172\u2013185","journal-title":"Neuroendocrinology"}],"container-title":["Die Chirurgie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-024-02117-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-024-02117-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-024-02117-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T12:02:58Z","timestamp":1724068978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00104-024-02117-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1007\/s00104-024-02117-7","relation":{},"ISSN":["2731-6971","2731-698X"],"issn-type":[{"type":"print","value":"2731-6971"},{"type":"electronic","value":"2731-698X"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"23 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>K.\u00a0Holzer<\/b>: A.\u00a0Finanzielle Interessen: 2023: Erstattung Reisekosten Schilddr\u00fcsenkongress M\u00fcnchen (bei Vortrag), Erstattung Reisekosten und Vortragst\u00e4tigkeit Schilddr\u00fcsenupdate, 2022: Entf\u00e4llt, 2021: entf\u00e4llt, 2020: Reisekosten Deutscher Krebskongress Berlin Vortrag, 2019: Erstattung Reisekosten Schilddr\u00fcsenkongress M\u00fcnchen (Vortrag), NET to go Vortragst\u00e4tigkeit.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: W2\u00a0Professorin der Endokrinen Chirurgie am Universit\u00e4tsklinikum Marburg | Stellv. Vorstand der Chirurgischen Arbeitsgemeinschaft Endokrinologie (CAEK). <b>D.K.\u00a0Bartsch<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Deutsche Forschungsgemeinschaft (DFG) Teilprojekt SP3\u00a0KFO 325.\u00a0\u2013 Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: Chirurgie Update 2023\/2024.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Direktor der Klinik f\u00fcr Viszeral\u2011, Thorax- und Gef\u00e4\u00dfchirurgie der Philipps-Universit\u00e4t Marburg.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}